Your browser doesn't support javascript.
loading
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Katayama, Ayaka; Starczynski, Jane; Toss, Michael S; Shaaban, Abeer M; Provenzano, Elena; Quinn, Cecily M; Callagy, Grace; Purdie, Colin A; Millican-Slater, Rebecca; Purnell, David; Chagla, Leena; Oyama, Tetsunari; Pinder, Sarah E; Chan, Steve; Ellis, Ian; Lee, Andrew H S; Rakha, Emad A.
Afiliação
  • Katayama A; Translational Medical Sciences Unit, School of Medicine, University of Nottingham, Nottingham, UK.
  • Starczynski J; Diagnostic Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Toss MS; Department of Cellular Pathology, University Hospitals Birmingham NHS Foundation Trust, Edgebaston, Birmingham, UK.
  • Shaaban AM; Translational Medical Sciences Unit, School of Medicine, University of Nottingham, Nottingham, UK.
  • Provenzano E; Department of Cellular Pathology, University Hospitals Birmingham NHS Foundation Trust, Edgebaston, Birmingham, UK.
  • Quinn CM; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgebaston, Birmingham, UK.
  • Callagy G; Department of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Purdie CA; Department of Histopathology, St. Vincent's University Hospital, Dublin, and School of Medicine, University College Dublin, Dublin, Ireland.
  • Millican-Slater R; Discipline of Pathology, School of Medicine, Lambe Institute for Translational Research, NUI, Galway, Ireland.
  • Purnell D; Department of Breast Pathology, Ninewells Hospital and Medical School, Dundee, UK.
  • Chagla L; Department of Histopathology, St James's University Hospital, Leeds, UK.
  • Oyama T; Histopathology Department, University Hospitals of Leicester, Leicester, UK.
  • Pinder SE; Burney Breast Unit, St Helens and Knowsley Teaching Hospital NHS Trust, Prescot, UK.
  • Chan S; Diagnostic Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Ellis I; Division of Cancer Studies, King's College London, Guy's Hospital, London, UK.
  • Lee AHS; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Rakha EA; Translational Medical Sciences Unit, School of Medicine, University of Nottingham, Nottingham, UK.
Histopathology ; 81(4): 511-519, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35879836
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aberrações Cromossômicas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Histopathology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aberrações Cromossômicas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Histopathology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido